Skip to main content

ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF.

Publication ,  Journal Article
Vazquez, S; Rondina, MT
Published in: Ann Intern Med
July 16, 2013

Duke Scholars

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

July 16, 2013

Volume

159

Issue

2

Start / End Page

JC8

Location

United States

Related Subject Headings

  • Warfarin
  • Stroke
  • Pyridones
  • Pyrazoles
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Atrial Fibrillation
  • Anticoagulants
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vazquez, S., & Rondina, M. T. (2013). ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF. Ann Intern Med, 159(2), JC8. https://doi.org/10.7326/0003-4819-159-2-201307160-02008
Vazquez, Sara, and Matthew T. Rondina. “ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF.Ann Intern Med 159, no. 2 (July 16, 2013): JC8. https://doi.org/10.7326/0003-4819-159-2-201307160-02008.
Vazquez, Sara, and Matthew T. Rondina. “ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF.Ann Intern Med, vol. 159, no. 2, July 2013, p. JC8. Pubmed, doi:10.7326/0003-4819-159-2-201307160-02008.

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

July 16, 2013

Volume

159

Issue

2

Start / End Page

JC8

Location

United States

Related Subject Headings

  • Warfarin
  • Stroke
  • Pyridones
  • Pyrazoles
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Atrial Fibrillation
  • Anticoagulants